approval
saveDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalApr 10, 2026 · 182d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalJan 20, 2026 · 262d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalJan 20, 2026 · 262d ago
- approvalDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalNov 4, 2025 · 339d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalFeb 12, 2025 · 604d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalFeb 12, 2025 · 604d ago
- approvalDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalDec 20, 2023 · 1024d ago
- approvalDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalMay 27, 2021 · 1961d ago
same company · ±60 days · 6
- approvalMEDROL: MEDROL (METHYLPREDNISOLONE) — FDA approvalJun 5, 2024
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalMay 14, 2024
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalMay 14, 2024
- approvalUNASYN: UNASYN (AMPICILLIN SODIUM) — FDA approvalMay 1, 2024
- approvaltaliglucerase alfa: ELELYSO (TALIGLUCERASE ALFA) — FDA approvalJul 10, 2024
- approvalABRILADA: ABRILADA (ADALIMUMAB-AFZB) — FDA approvalApr 30, 2024
comments(0)
5-min edit window · permanent after that